SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-052863
Filing Date
2019-10-09
Accepted
2019-10-09 20:01:37
Documents
1
Period of Report
2019-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6962
  Complete submission text file 0001209191-19-052863.txt   8593
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 206 BEDMINSTER NJ 07921
Business Address
Berg Aaron (Reporting) CIK: 0001770259 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 191145149